| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1000: Iptacopan for treating paroxysmal nocturnal haemoglobinuria |
|
Medicine details |
|
| Medicine name | iptacopan |
| Formulation | Oral formulation |
| Reference number | 5142 |
| Indication | Treatment of paroxysmal nocturnal haemoglobinuria (PNH) in adults with active haemolysis |
| Company | Novartis Oncology |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 10/05/2024 |
| NICE guidance | TA1000: Iptacopan for treating paroxysmal nocturnal haemoglobinuria
|